Skip to main content
. Author manuscript; available in PMC: 2022 May 15.
Published in final edited form as: J Immunol. 2021 Oct 4;207(10):2399–2404. doi: 10.4049/jimmunol.2100608

Figure 4. Adoptive transfer of pulmonary T cells does not protect against SARS-CoV-2 challenge.

Figure 4.

A) Total T cells from naïve hACE2 mice or total Teff from hACE2 immune animals were purified and 3.5x105 cells were intratracheally transferred into naïve hACE2 animals or B) 1.4x106 total Teff from hACE2 immune animals were intravenously transferred into naïve hACE2 animals. One day later, mice were intranasally challenged with 102 PFU of SARS-CoV-2 and monitored for signs of illness. n=10 mice/group (A) or n=6-8 mice/group (B) and are combined from 2 independent experiments. Statistically significant differences in survival between groups was determined using a log-rank (Mantel-Cox) test and found not to be statistically significant.